Influence of Peak Inspiratory Flow Rates and Pressure Drops on Inhalation Performance of Dry Powder Inhalers

被引:16
|
作者
Hira, Daiki [1 ]
Okuda, Tomoyuki [1 ]
Ichihashi, Mika [1 ]
Mizutani, Ayano [1 ]
Ishizeki, Kazunori [2 ]
Okada, Toyoko [2 ]
Okamoto, Hirokazu [1 ]
机构
[1] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan
[2] Hitachi Automot Syst Ltd, Gunma 3720023, Japan
关键词
dry powder inhaler; inhalation device; inspiratory flow rate; human inspiratory flow simulator; powder formulation; STANDARDIZED ENTRAINMENT TUBES; COMPUTATIONAL FLUID-DYNAMICS; IN-VITRO; DRUG-DELIVERY; LACTOSE; FORMULATION; DESIGN; BLENDS; MONOHYDRATE; RESISTANCE;
D O I
10.1248/cpb.60.341
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of this study was to reveal the relationship between human inspiratory flow patterns and the concomitant drops in pressure in different inhalation devices, and the influence of the devices on inhalation performance. As a model formulation for inhalers, a physically mixed dry powder composed of salbutamol sulfate and coarse lactose monohydrate was selected. The drops in pressure at 28.3 L/min of three inhalation devices, Single-type, Dual-type, and Reverse-type, was 1.0, 5.1, and 8.7 kPa, respectively. Measurements of human inspiratory patterns revealed that although the least resistant device (Single) had large inter- and intra-individual variation of peak flow rate (PFR), the coefficients of variation of PFR of the three devices were almost the same. In tests with a human inspiratory flow simulator in vitro, inhalation performance was higher, but the variation in inhalation performance in the range of human flow patterns was wider, for the more resistant device. To minimize the intra- and inter-individual variation in inhalation performance for the model formulation in this study, a formulation design that allows active pharmaceutical ingredient to detach from the carrier with a lower inhalation flow rate is needed.
引用
收藏
页码:341 / 347
页数:7
相关论文
共 50 条
  • [31] Dry powder inhalation, part 1: ancient history and precursors to modern dry powder inhalers
    de Boer, Anne Haaije
    Hagedoorn, Paul
    Grasmeijer, Floris
    EXPERT OPINION ON DRUG DELIVERY, 2022, 19 (09) : 1033 - 1044
  • [32] Peak inspiratory flow rates generated through the Novolizer® and the Turbuhaler® dry powder inhaler devices by children with stable asthma
    von Berg, Andrea
    Kremer, Hans-Joachim
    Ellers-Lenz, Barbara
    Conrad, Frank
    Erb, Katharina
    Maus, Joachim
    Hermann, Robert
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2007, 20 (01): : 50 - 58
  • [33] INFLUENCE OF MAGNESIUM STEARATE ON THE PERFORMANCE AND DISSOLUTION OF BUDESONIDE IN DRY POWDER INHALERS
    Depasquale, R.
    Shur, J.
    Price, R.
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2013, 26 (04) : A254 - A254
  • [34] Consider the turbulent energy not inhalation flow when patients use dry powder inhalers (DPIs)
    Azouz, Wahida
    Chetcuti, Philip
    Hosker, Harold
    Saralaya, Dinesh
    Chrystyn, Henry
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [35] Effect of rise in simulated inspiratory flow rate and carrier particle size on powder emptying from dry powder inhalers
    Chavan, V
    Dalby, R
    AAPS PHARMSCI, 2000, 2 (02):
  • [36] Effect of rise in simulated inspiratory flow rate and carrier particle size on powder emptying from dry powder inhalers
    Chavan V.
    Dalby R.
    AAPS PharmSci, 2 (2): : 1 - 7
  • [37] Measurement of patient inhalation rates for different dry powder inhalers (DPIs) using the in-check dial
    Tarsin, W
    Kassi, K
    Corrado, OJ
    Chrystyn, H
    THORAX, 2000, 55 : A63 - A63
  • [38] The investigation of inhalation continuous duration for dry powder inhalers in asthmatic patients
    Niimi, Takashi
    Sakurai, Yukari
    Sakurai, Yukari
    Asano, Takamitsu
    Halata, Akiko
    Tomita, Yuki
    Takano, Yuko
    Sato, Shlgeki
    Akita, Kenji
    Banno, Masashi
    Matsushita, Ryo
    Ibata, Hidenori
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [39] Investigating Improving Powder Deagglomeration Via Dry Powder Inhalers at a Low Inspiratory Flow Rate by Employing Add-On Spacers
    Ehtezazi, T.
    Allanson, D. R.
    Jenkinson, I. D.
    Shrubb, I.
    O'Callaghan, C.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (12) : 5212 - 5221
  • [40] Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis
    Stass, Heino
    Nagelschmitz, Johannes
    Kappeler, Dominik
    Sommerer, Knut
    Patzlaff, Astrid
    Weimann, Boris
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (03) : 156 - 163